Global In-Silico Drug Discovery Market, By Type (Software as a Service, Consultancy as a Service, Software), Type of Large Molecule (Antibodies, Proteins, Peptides, Nucleic Acids, Vectors), Workflow (Discovery, Target Identification, Reverse Docking, Bioinformatics, Protein Structure Prediction, Target Validation, Lead Discovery, Pharmacophore, Library Design, Preclinical Tests, Clinical Trials), Target Therapeutic Area (Human Immunodeficiency Virus (HIV), Infectious Diseases, Metabolic Disorders, Mental Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders, Skin Disorders, Urogenital Disorders, Autoimmune Disorders, Blood Disorders, Cardiovascular Disorders, Gastrointestinal and Digestive Disorders, Hormonal Disorders, Others), End User (Contract Research Organizations, Pharmaceutical Industry, Academic and Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
In-silico drug discovery market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 7,296.0 million by 2028 and will grow at a CAGR of 13.6% in the above mentioned forecast period.
The in-silico drug discovery methods usually help to find drug targets through bioinformatics tools. These methods can also be used to analyze target structures for possible binding sites, generate candidate molecules, check for their drug likeness, rank them according to their binding affinities, dock these molecules with the target and further optimize molecules to progress binding characteristics.
The rise in the volume of drug discovery data is amongst the important factor expected to intensify the growth and demand of in-silico drug discovery market. In addition, the rise in the high growth in the biomarker identification area and rise in the focus on reduction in readmission rates and medical errors are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the computational technological advancements in the field of computational biology and rapid advancements in in-silico drug discovery techniques are also likely to enhance the growth of the market. Furthermore, the cost effective and the high adoption of in-silico drug designing services are also amongst the significant factors expected to fuel the growth of the in-silico drug discovery market.
The rapid increase number of drug discovery projects, rise in the research in many therapeutic areas and end number of R&D in many pharmaceutical companies are anticipated to offer significant growth opportunities for the in-silico drug discovery market in the forecast period of 2021 to 2028.
However, the downward pricing pressure and outsourcing for services are expected to curb the growth of the in-silico drug discovery market, whereas the presence of open-source software packages for drug discovery can challenge the growth of the in-silico drug discovery market.
This in-silico drug discovery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on in-silico drug discovery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global In-Silico Drug Discovery Market Scope and Market Size
In-silico drug discovery market is segmented on the basis of type, type of large molecule, workflow, target therapeutic area and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the in-silico drug discovery market is segmented into software as a service, consultancy as a service and software.
- Based on type of large molecule, the in-silico drug discovery market is segmented into antibodies, proteins, peptides, nucleic acids and vectors.
- The workflow segment of the in-silico drug discovery market is segmented into discovery, target identification, reverse docking, bioinformatics, protein structure prediction, target validation, lead discovery, pharmacophore, library design, preclinical tests and clinical trials.
- Based on target therapeutic area, the in-silico drug discovery market is segmented into human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, skin disorders, urogenital disorders, autoimmune disorders, blood disorders, cardiovascular disorders, gastrointestinal and digestive disorders, hormonal disorders and others.
- On the basis of end user, the in-silico drug discovery market is segmented into contract research organizations, pharmaceutical industry, academic and research institutes and others.
In-Silico Drug Discovery Market Country Level Analysis
In-silico drug discovery market is analyzed and market size insights and trends are provided by country, type, type of large molecule, workflow, target therapeutic area and end user as referenced above.
The countries covered in the in-silico drug discovery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the in-silico drug discovery market owing to the rapid technological advancements, strong presence of strong vendors and the presence of large patient population suffering from various chronic and infectious diseases. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the number of academics and extensive research in cancer and diabetes.
The country section of the in-silico drug discovery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
In-silico drug discovery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for in-silico drug discovery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the in-silico drug discovery market. The data is available for historic period 2010 to 2019.
Competitive Landscape and In-Silico Drug Discovery Market Share Analysis
In-silico drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to in-silico drug discovery market.
The major players covered in the in-silico drug discovery market report are Albany Molecular Research Inc., Certara, Charles River Laboratories, Chemical Computing Group ULC, GenScript, LakePharma, Inc., Sygnature Discovery, Abzena Ltd., BioNTech SE, and Creative Biostructure among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global In-Silico Drug Discovery Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.